Canyon Lab: Strategic Acquisition of iuvo BioScience's Lab Services
Deal News | Jan 07, 2025 | Ampersand Capital Partners
Canyon Labs has announced its strategic acquisition of iuvo BioScience’s Lab Services and Consulting Businesses. This move is aimed at enhancing Canyon Lab’s end-to-end development solutions. The acquisition is supported by Ampersand Capital Partners, reflecting a strategic expansion initiative to strengthen Canyon Lab's comprehensive service offerings. iuvo BioScience is known for its expertise in lab services and consulting, a valuable addition for Canyon Lab's growing capabilities in the sector.
Sectors
- Life Sciences
- Private Equity
Geography
- United States – The companies involved, such as Canyon Lab and iuvo BioScience, are operating within the United States, making this geographical context relevant.
Industry
- Life Sciences – The article involves Canyon Lab's acquisition of iuvo BioScience’s Lab Services, indicating its relevance to the life sciences sector, focusing on lab services and biotechnology consulting.
- Private Equity – Ampersand Capital Partners, a private equity firm, is backing the acquisition, highlighting the financial dynamics of the deal indicative of private equity involvement.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Canyon Lab | Acquirer | Company | Canyon Lab is the acquiring entity, expanding its lab services and consulting capabilities through this acquisition. |
| iuvo BioScience | Target Company | Company | iuvo BioScience provides lab services and consulting, whose division is being acquired by Canyon Lab. |
| Ampersand Capital Partners | Private Equity Backer | Company | A private equity firm supporting Canyon Lab's strategic acquisition of iuvo BioScience’s assets. |